Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-015665
Filing Date
2019-06-05
Accepted
2019-06-05 18:47:44
Documents
1
Period of Report
2019-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3962
  Complete submission text file 0000899243-19-015665.txt   5462
Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Deshpande Milind (Reporting) CIK: 0001378588 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 19881168

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations